On Holding, a Swiss-based athletic shoe and performance sportswear company, has completed its initial public offering (IPO) on the NYSE, consisting of an offering of 31,100,000 Class A ordinary shares, of which 25,442,391 were offered by On
Tags :Karin Mattle
Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross
On January 29, 2021, MTH Retail Group Holding GmbH (MTH), OFFICE WORLD Holding AG (OWH), PEG Papeteristen Einkaufsgenossenschaft (PEG) and OFFIX Holding AG announced to combine their Swiss businesses in a new joint venture under the name
The law firm acted as legal advisor in connection with the global offering of 6,900,000 shares (including shares delivered in the form of American Depositary Shares, or ADSs). The team comprised partner Frank Gerhard (pictured), associates
Homburger is advising Liberty Global on the transaction. The Homburger team is led by partners Daniel Daeniker (pictured left) and Daniel Hasler (pictured right) (Corporate / M&A) and includes partners Richard Stäuber, Franz Hoffet (
Homburger acted as a legal counsel to Winemaker in connection with the setting-up of its business. The team was led by partners Claude Lambert (Corporate/M&A - pictured), Luca Dal Molin (IP/IT) and
Lenz & Staehelin is advising Sunrise in this transformational transaction. The team includes partners Hans-Jakob Diem and Tino Gaberthüel. Homburger is advising Liberty Global with a team led by partners Daniel Daeniker and Daniel Hasler
Homburger advised Molecular Partners in this transaction with a team led by partner Dieter Gericke. Bär & Karrer acted as legal counsel to the banking syndicate. The team included partner Thomas Reutter
Becton, Dickinson and Company (BD) acquired Straub Medical, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease.
